- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01724567
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training (CUT-IT)
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training: A Randomized Clinical Trial
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
In western countries 80 % of patients with ischemic heart disease (IHD) are overweight (BMI > 25). Weight loss using a low energy diet (LED, 800 - 1000 kcal/day) has been shown to induce a considerable weight loss in obese but otherwise healthy patients and to reduce the risk of cardiovascular disease and diabetes in these subjects. Additionally, a British study using a very low energy diet (VLED, 600 kcal/day) to obtain weight loss, has shown that subject with diagnosed type 2 diabetes had their blood glucose normalized after an 8 week VLED. However, the effect of LED has never been examined in overweight patients with IHD.
Several studies have shown that patients with IHD have a beneficial effect of exercise training regarding mortality and reduction in cardiovascular risk factors. A Norwegian group has shown that aerobic interval training results in the biggest increase in maximal oxygen uptake (VO2max). A high VO2max is correlated to decreased mortality in patients with IHD.
In conclusion, weight loss and exercise are known strategies in preventing progression of IHD and development of type 2 diabetes in these patients, however a head-to-head comparison of the two methods has never been made and it is unknown which intervention is the most effective in improving cardiovascular risk profile. Furthermore, several mechanisms behind the known beneficial effect of these interventions are unknown.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Copenhagen, Dänemark, 2400
- Bispebjerg Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Stable Ischemic Heart Disease
- BMI 28 - 40 kg/m2
Exclusion criteria:
- Known Diabetes Mellitus
- Repeated Fasting plasma glucose ≥ 7 mmol/L or Hba1c > 7 %
- Severe or moderate valve disease
- Main stem stenosis
- Severe heart failure, Ejection Fraction < 35 %
- Physical or mental disability which are expected to prevent completion of intervention
- Severe Chronic obstructive Pulmonary Disease (COPD) (FEV1 < 50 % of expected) or asthma
- Active cancer
- Severe kidney (GFR < 40 ml/hour) or severe liver disease
- Severe ischemia or arrhythmias during exercise test
- 2. or 3. degree atrio-ventricular (AV) block, not protected by pacemaker
- Organised training more than 2 times a week prior to inclusion
- Significant weight loss or weight gain (> 5 %)3 month prior to inclusion
- Not able to comprehend written and oral informed consent
- Hormone treatment
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Weight Loss
12 weeks of Low Calorie Diet to obtain a 10 - 15 % weight loss.
Followed by 40 weeks on a weight maintenance diet and interval training 2 times a week.
|
Low calorie diet approx.
1000 kcal/day for 8 - 10 weeks to obtain a 10 - 15 % weight loss.
|
Experimental: Interval Training
12 weeks of interval training 3 times a week followed by 40 weeks of interval training 2 times a week.
|
Interval training (IT) on an exercise bike 3 times a week, for the first 12 weeks, followed by 40 weeks of IT 2 times a week on exercise bike.
Each training session consists of active intervals with a total duration of 16 minutes (durations intervals between 1 and 4 minutes) at 90% of maximal heart rate.
Active intervals are separated by active pauses at 60% of maximal heart rate.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Coronary Flow Reserve following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed by a non-invasive echocardiographic Doppler measurement
|
0, 12 and 52 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Heart Rate Variability and silent ischemia following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed by Holter Monitoring for 24 - 48 hours
|
0, 12 and 52 weeks
|
Change in endothelial function following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Using the Endopat 2000 from Itamar
|
0, 12 and 52 weeks
|
Change in systolic and diastolic function following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed by echocardiography resting and during physiological and medical stress.
|
0, 12 and 52 weeks
|
Change in body composition following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed by anthropometry, dual X-ray absorptiometry (DXA) (lean body mass, percentage adipose tissue) and abdominal MRI (liver fat, muscle fat, subcutaneous fat and visceral fat at the level of L3).
|
0, 12 and 52 weeks
|
Change in myocardial blood flow following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed by positron emission tomography of the heart
|
0, 12 and 52 weeks
|
Change in insulin action, beta cell function and incretin secretion following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
A Oral Glucose Tolerance Test is performed.
|
0, 12 and 52 weeks
|
Change in oxidized lipids and lipoprotein particle size following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
Change in peak oxygen uptake (VO2max) following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
Assessed using a bicycle ergometer
|
0, 12 and 52 weeks
|
Change in blood pressure following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
Change in inflammatory markers in urin, blood and adipose tissue following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
Change in quality of life following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
Change in ceramides, diacylglycerol og endocannabinoid (CB)-1 receptors in adipose tissue following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
Change in hormones derived from adipose tissue following the diet or training intervention and a maintenance period
Zeitfenster: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Eva Prescott, MD, DMsc, Bispebjerg Hospital
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Pedersen LR, Olsen RH, Frederiksen M, Astrup A, Chabanova E, Hasbak P, Holst JJ, Kjaer A, Newman JW, Walzem R, Wisloff U, Sajadieh A, Haugaard SB, Prescott E. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovasc Disord. 2013 Nov 19;13:106. doi: 10.1186/1471-2261-13-106.
- Pedersen LR, Olsen RH, Jurs A, Astrup A, Chabanova E, Simonsen L, Wisloff U, Haugaard SB, Prescott E. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial. Eur J Prev Cardiol. 2015 Aug;22(8):1009-17. doi: 10.1177/2047487314545280. Epub 2014 Jul 31.
- Pedersen LR, Olsen RH, Anholm C, Astrup A, Eugen-Olsen J, Fenger M, Simonsen L, Walzem RL, Haugaard SB, Prescott E. Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial. Cardiovasc Diabetol. 2019 Oct 1;18(1):127. doi: 10.1186/s12933-019-0934-x.
- Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, Haugaard SB, Prescott E. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial. Atherosclerosis. 2016 Mar;246:221-8. doi: 10.1016/j.atherosclerosis.2016.01.001. Epub 2016 Jan 13.
- Pedersen LR, Olsen RH, Jurs A, Anholm C, Fenger M, Haugaard SB, Prescott E. A randomized trial comparing the effect of weight loss and exercise training on insulin sensitivity and glucose metabolism in coronary artery disease. Metabolism. 2015 Oct;64(10):1298-307. doi: 10.1016/j.metabol.2015.07.007. Epub 2015 Jul 17.
- Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol. 2015 Apr 15;185:229-35. doi: 10.1016/j.ijcard.2015.03.118. Epub 2015 Mar 11.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- CUT-IT
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Weight Loss
-
University of PennsylvaniaAbgeschlossenFettleibigkeitVereinigte Staaten
-
Drexel UniversityAbgeschlossenFettleibigkeit | ÜbergewichtVereinigte Staaten
-
Yale UniversityAbgeschlossenGewichtsverlust | Übergewicht und Adipositas | NahrungssuchtVereinigte Staaten
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)AbgeschlossenFettleibigkeitVereinigte Staaten
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... und andere MitarbeiterAbgeschlossenÜbergewicht und AdipositasVereinigte Staaten
-
University of VermontAbgeschlossen
-
Walter Reed Army Medical CenterAbgeschlossenDiabetes mellitus Typ 2
-
California Polytechnic State University-San Luis...AbgeschlossenGewichtsverlustVereinigte Staaten
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundAbgeschlossenNierenkrebs | Brustkrebs | Darmkrebs | Prostatakrebs | Blasenkrebs | Endometriumkarzinom | Melanom (Haut) | GallenblasenkrebsVereinigte Staaten
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Rekrutierung